PROCEPT BioRobotics Corp. (PRCT)
29.10
+0.32
(+1.11%)
USD |
NASDAQ |
Jun 10, 16:00
29.10
0.00 (0.00%)
After-Hours: 19:14
PROCEPT BioRobotics Enterprise Value : 1.470B for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 1.470B |
| June 08, 2026 | 1.445B |
| June 05, 2026 | 1.416B |
| June 04, 2026 | 1.369B |
| June 03, 2026 | 1.330B |
| June 02, 2026 | 1.355B |
| June 01, 2026 | 1.418B |
| May 29, 2026 | 1.330B |
| May 28, 2026 | 1.380B |
| May 27, 2026 | 1.338B |
| May 26, 2026 | 1.395B |
| May 22, 2026 | 1.483B |
| May 21, 2026 | 1.479B |
| May 20, 2026 | 1.432B |
| May 19, 2026 | 1.307B |
| May 18, 2026 | 1.313B |
| May 15, 2026 | 1.319B |
| May 14, 2026 | 1.334B |
| May 13, 2026 | 1.295B |
| May 12, 2026 | 1.465B |
| May 11, 2026 | 1.338B |
| May 08, 2026 | 1.278B |
| May 07, 2026 | 1.280B |
| May 06, 2026 | 1.244B |
| May 05, 2026 | 1.266B |
| Date | Value |
|---|---|
| May 04, 2026 | 1.246B |
| May 01, 2026 | 1.234B |
| April 30, 2026 | 1.201B |
| April 29, 2026 | 1.068B |
| April 28, 2026 | 1.143B |
| April 27, 2026 | 1.204B |
| April 24, 2026 | 1.219B |
| April 23, 2026 | 1.212B |
| April 22, 2026 | 1.261B |
| April 21, 2026 | 1.241B |
| April 20, 2026 | 1.297B |
| April 17, 2026 | 1.263B |
| April 16, 2026 | 1.228B |
| April 15, 2026 | 1.293B |
| April 14, 2026 | 1.232B |
| April 13, 2026 | 1.167B |
| April 10, 2026 | 1.153B |
| April 09, 2026 | 1.156B |
| April 08, 2026 | 1.190B |
| April 07, 2026 | 1.152B |
| April 06, 2026 | 1.185B |
| April 02, 2026 | 1.262B |
| April 01, 2026 | 1.275B |
| March 31, 2026 | 1.255B |
| March 30, 2026 | 1.233B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 82.51B |
| PAVmed, Inc. | 29.11M |
| Abbott Laboratories | 186.33B |
| AngioDynamics, Inc. | 487.94M |
| Alphatec Holdings, Inc. | 1.742B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.64M |
| Revenue (Quarterly) | 83.13M |
| Total Expenses (Quarterly) | 114.77M |
| EPS Diluted (Quarterly) | -0.5599 |
| Gross Profit Margin (Quarterly) | 64.89% |
| Profit Margin (Quarterly) | -38.06% |
| Earnings Yield | -6.29% |
| Normalized Earnings Yield | -6.287 |